Date:10/8/2009

truments cut and coagulate (seal tissue) at lower temperatures, thus minimizing lateral thermal tissue spread. In turn, this results in minimal charring of the tissue compared to electrocautery. HARMONIC devices have been used in more than 8 million surgical procedures worldwide since 1995 in a variety of general surgery, gynecologic, colorectal, otolaryngology, urologic, and vessel harvesting procedures.

About Ethicon Endo-Surgery

Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com.

SOURCE Ethicon Endo-Surgery

'/>"/>

SOURCE Ethicon Endo-Surgery Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
2. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
3. USC Keck School of Medicines Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
4. Diamyd(R) Study Published in Prestigious New England Journal of Medicine
5. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
6. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
7. SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders
8. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
9. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
10. OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting
11. New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal